Attributes of alternatively activated (M2) macrophages R Shrivastava, N Shukla Life sciences 224, 222-231, 2019 | 92 | 2019 |
Therapeutic targeting of poly (ADP‐ribose) polymerase‐1 (PARP1) in cancer: Current developments, therapeutic strategies, and future opportunities J Rajawat, N Shukla, DP Mishra Medicinal Research Reviews 37 (6), 1461-1491, 2017 | 57 | 2017 |
Skp2 inhibits osteogenesis by promoting ubiquitin–proteasome degradation of Runx2 G Thacker, Y Kumar, MP Khan, N Shukla, I Kapoor, JK Kanaujiya, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1863 (4), 510-519, 2016 | 35 | 2016 |
Identification of potential histone deacetylase1 (HDAC1) inhibitors using multistep virtual screening approach including SVM model, pharmacophore modeling, molecular docking … S Krishna, AD Lakra, N Shukla, S Khan, DP Mishra, S Ahmed, MI Siddiqi Journal of Biomolecular Structure and Dynamics 38 (11), 3280-3295, 2020 | 14 | 2020 |
Ubiquitin ligase, Fbw7, targets CDX2 for degradation via two phosphodegron motifs in a GSK3β-dependent manner Y Kumar, N Shukla, G Thacker, I Kapoor, S Lochab, MLB Bhatt, ... Molecular Cancer Research 14 (11), 1097-1109, 2016 | 13 | 2016 |
Integrated support vector machine and pharmacophore based virtual screening driven identification of thiophene carboxamide scaffold containing compound as potential PARP1 inhibitor M Singh, J Rajawat, J Kuldeep, N Shukla, DP Mishra, MI Siddiqi Journal of Biomolecular Structure and Dynamics 40 (18), 8494-8507, 2022 | 7 | 2022 |
PARP1 inhibition impedes Warburg effect in breast cancer cells through modulation of the miR-98/STAT3 signaling axis N Shukla Cancer Research 78 (13_Supplement), 4425-4425, 2018 | 1 | 2018 |
Poly (ADP-Ribose) polymerase 1: a therapeutic hope in gynecologic cancers J Rajawat, N Shukla, DP Mishra Front Biosci (Schol Ed) 9, 343-356, 2017 | 1 | 2017 |
Abstract 1390: Multiplex measurements of the impacts of ACE2 sequence and cell surface abundance during SARS-like coronavirus entry KM Nidhi Shukla, Nisha Kamath, Sarah Roelle, Anna Bruchez DiscoverBMB ASBMB, 2023 | | 2023 |
MicroRNA‐203 regulates cell junction and adhesion proteins by modulating Zeb1/Vimentin axis in breast cancer cells after PARP1 inhibition. N Shukla, J Rajawat, DP Mishra The FASEB Journal 32, 804.12-804.12, 2018 | | 2018 |